Thermo Fisher's Q4 Sales Surge 126 Percent, Though Profits Tumble My More Than Half | GenomeWeb
This update includes a $125-million charge related to the Thermo-Fisher merger, which negatively affected fourth-quarter 2006 profit.
 
NEW YORK (GenomeWeb News) — Thermo Fisher Scientific today said fourth-quarter revenues increased 126 percent as R&D spending rose 36 percent and profit declined by more than half on merger-related charges.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $1.67 billion from $741 million year over year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.